Suppr超能文献

维拉帕米与肺动脉高压

Verapamil and pulmonary hypertension.

作者信息

Landmark K, Refsum A M, Simonsen S, Storstein O

出版信息

Acta Med Scand. 1978;204(4):299-302. doi: 10.1111/j.0954-6820.1978.tb08443.x.

Abstract

We report on the effect of verapamil in 12 patients suffering from pulmonary hypertension. The drug caused a slight, but statistically significant decrease in mean pulmonary artery pressure and in the work performance by the right ventricle. The mean pressure of the right atrium, the end-diastolic pressure of the right ventricle, the pulmonary arteriolar resistance, the cardiac index and the stroke volume were not significantly changed, however, and there was a wide spread of the values observed. In some patients the drug exerted a marked negative inotropic effect, with a concomitant increase in the pulmonary arteriolar resistance.

摘要

我们报告了维拉帕米对12例肺动脉高压患者的疗效。该药使平均肺动脉压和右心室作功略有降低,但具有统计学意义。然而,右心房平均压、右心室舒张末期压力、肺小动脉阻力、心脏指数和每搏输出量均无显著变化,且观察值分布较广。在一些患者中,该药产生了明显的负性肌力作用,同时肺小动脉阻力增加。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验